- Home
- POAI vs SDRL Comparison
POAI vs SDRL Comparison
Compare POAI & SDRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- SDRL
- Stock Information
- Founded
- POAI 2002
- SDRL 2005
- Country
- POAI United States
- SDRL Bermuda
- Employees
- POAI 35
- SDRL N/A
- Industry
- POAI Industrial Specialties
- SDRL Oil & Gas Production
- Sector
- POAI Health Care
- SDRL Energy
- Exchange
- POAI Nasdaq
- SDRL Nasdaq
- Market Cap
- POAI 9.9M
- SDRL N/A
- IPO Year
- POAI N/A
- SDRL N/A
- Fundamental
- Price
- POAI $1.30
- SDRL $18.92
- Analyst Decision
- POAI Hold
- SDRL Strong Buy
- Analyst Count
- POAI 1
- SDRL 6
- Target Price
- POAI N/A
- SDRL $59.60
- AVG Volume (30 Days)
- POAI 8.1M
- SDRL 901.8K
- Earning Date
- POAI 05-13-2025
- SDRL 05-13-2025
- Dividend Yield
- POAI N/A
- SDRL N/A
- EPS Growth
- POAI N/A
- SDRL 54.46
- EPS
- POAI N/A
- SDRL 6.37
- Revenue
- POAI $1,623,817.00
- SDRL $1,315,000,000.00
- Revenue This Year
- POAI $486.27
- SDRL $5.55
- Revenue Next Year
- POAI $65.50
- SDRL $16.86
- P/E Ratio
- POAI N/A
- SDRL $3.96
- Revenue Growth
- POAI N/A
- SDRL N/A
- 52 Week Low
- POAI $0.55
- SDRL $21.60
- 52 Week High
- POAI $3.06
- SDRL $56.46
- Technical
- Relative Strength Index (RSI)
- POAI 48.03
- SDRL 23.14
- Support Level
- POAI $1.26
- SDRL $24.62
- Resistance Level
- POAI $1.58
- SDRL $25.88
- Average True Range (ATR)
- POAI 0.21
- SDRL 0.93
- MACD
- POAI 0.01
- SDRL -0.10
- Stochastic Oscillator
- POAI 16.13
- SDRL 5.80
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.